Biosafe says in partnership with its Indian distributor Span Healthcare, it has achieved major expansion of its stem cell banking business in India.
In the public stem cell banking area, Jeevan blood bank and research centre
in Chennai is expanding its programme and will process its full volume of stem
cell samples with Biosafe's proprietary Sepax cell separation system and
Coolmix cryo-preparation cooling and mixing device.
On the family banking side, the renowned companies Cordlife India and
Cryobanks international are also moving to automated processing exclusively
Such expansion is a milestone as the majority of cord blood samples in India
will now be processed with Biosafe technology.
Olivier Waridel, CEO of the Biosafe Group, said in Basel, Switzerland: "These recent
wins [of new contracts], illustrate the potential of Biosafe's Sepax technology in the BRIC
"Biosafe demonstrates its ability to meet customer expectations
through its vast portfolio of processing solutions and is committed to further
support stem cell banking expansion in India together with Span
For further information: http://www.biosafe.ch
Photo: Biochemistry from Shutterstock